Tango Total Current Assets from 2010 to 2024

TNGX Stock  USD 3.10  0.16  5.44%   
Tango Therapeutics Total Current Assets yearly trend continues to be fairly stable with very little volatility. Total Current Assets will likely drop to about 318.9 M in 2024. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2010-12-31
Previous Quarter
346.5 M
Current Value
318.9 M
Quarterly Volatility
158.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tango Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tango Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.6 M, Interest Expense of 3.6 M or Selling General Administrative of 22.1 M, as well as many indicators such as Price To Sales Ratio of 19.37, Dividend Yield of 0.0 or PTB Ratio of 6.45. Tango financial statements analysis is a perfect complement when working with Tango Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tango Therapeutics Correlation against competitors.
For more information on how to buy Tango Stock please use our How to Invest in Tango Therapeutics guide.

Latest Tango Therapeutics' Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Tango Therapeutics over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Tango Therapeutics' Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tango Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Tango Total Current Assets Regression Statistics

Arithmetic Mean142,881,061
Geometric Mean83,096,422
Coefficient Of Variation111.23
Mean Deviation134,966,748
Median41,656,000
Standard Deviation158,928,741
Sample Variance25258.3T
Range450.7M
R-Value0.77
Mean Square Error10927.4T
R-Squared0.60
Significance0.0007
Slope27,487,741
Total Sum of Squares353616.8T

Tango Total Current Assets History

2024318.9 M
2023346.5 M
2022375.3 M
2021492.3 M
2020193.6 M

About Tango Therapeutics Financial Statements

Tango Therapeutics investors use historical fundamental indicators, such as Tango Therapeutics' Total Current Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tango Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Current Assets346.5 M318.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tango Stock Analysis

When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.